UMIN-CTR Clinical Trial

Recruitment status Suspended
Unique ID issued by UMIN UMIN000039557
Receipt No. R000045111
Scientific Title Posterior medial quadratus lumborum block provided effective analgesia for lumbar spinal surgery: A Randomized Controlled Trial
Date of disclosure of the study information 2020/02/21
Last modified on 2020/04/02 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Posterior medial quadratus lumborum block provided effective analgesia for lumbar spinal surgery: A Randomized Controlled Trial
Acronym Posterior medial quadratus lumborum block provided effective analgesia for lumbar spinal surgery: A Randomized Controlled Trial
Scientific Title Posterior medial quadratus lumborum block provided effective analgesia for lumbar spinal surgery: A Randomized Controlled Trial
Scientific Title:Acronym Posterior medial quadratus lumborum block provided effective analgesia for lumbar spinal surgery: A Randomized Controlled Trial
Region
Japan

Condition
Condition Lumbar spinal surgery
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Analgesic efficacy in perioperative period
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The cumulative fentanyl consumption administered for rescue analgesia during the first 24 hours after surgery.
Key secondary outcomes 1.The number of fentanyl demands and delivered for rescue analgesia
2.The Extent of sensory blockade related to the posterior branches of lumbar spinal nerve (cold tests)
3. The pain score on the visual analogue scale (VAS) at rest and during mobilization in the first 48 hours after surgery.
4. The number of patients who complaint of nausea and vomiting during the first 24 hours after surgery.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Posterior medial quadratus lumborum block with general anesthesia (Q group)
Interventions/Control_2 Placebo posterior medial quadratus lumborum block with general anesthesia (C group)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Lumbar spinal surgery
Key exclusion criteria lumbar spinal surgery more than three levels
revision surgery
chronic opioids preoperatively for more than three months
Allergic to levobupivacaine.
Reoperation during the first fotry-eight hours postoperative
Target sample size 60

Research contact person
Name of lead principal investigator
1st name Hironobu
Middle name
Last name Ueshima
Organization Showa university hospital
Division name Anesthesiology
Zip code 142-8666
Address 1-5-8, hatanodai, shinagawa-ku
TEL 0337848575
Email ueshimhi@yahoo.co.jp

Public contact
Name of contact person
1st name Hironobu
Middle name
Last name Ueshima
Organization Showa university hospital
Division name Amesthesiology
Zip code 142-8666
Address 1-5-8, hatanodai, shinagawa-ku
TEL 0337848575
Homepage URL
Email ueshimhi@yahoo.co.jp

Sponsor
Institute Showa university hospital
Institute
Department

Funding Source
Organization Showa university hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Showa university hospital
Address 1-5-8, hatanodai, shinagawa-ku
Tel 0337848575
Email ueshimhi@yahoo.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 02 Month 21 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 73
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Suspended
Date of protocol fixation
2018 Year 04 Month 13 Day
Date of IRB
2018 Year 04 Month 13 Day
Anticipated trial start date
2018 Year 05 Month 01 Day
Last follow-up date
2021 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 02 Month 21 Day
Last modified on
2020 Year 04 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045111